Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs LMWH for Thromboprophylaxis in Acute SCI
NCT03200613Phase 2Terminated
- Sponsor
- McMaster University
- Start
- Sep 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in venous thromboembolism (VTE), sponsored by McMaster University. Started Sep 2017; status: terminated.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03200613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200613.